TP53 and melanoma: Furthermore, small molecules, like MJ25, have been identified as potential p53 activators, showing cytotoxic effects on melanoma cells by inhibiting thioredoxin reductase 1 (TrxR1) and enhancing p53-dependent transactivation [170].